Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Benign prostatic hyperplasia.

Paolone DR.

Clin Geriatr Med. 2010 May;26(2):223-39. doi: 10.1016/j.cger.2010.02.010. Review.

PMID:
20497842
2.

Evidence-based guidelines for the management of lower urinary tract symptoms related to uncomplicated benign prostatic hyperplasia in Italy: updated summary.

Spatafora S, Conti G, Perachino M, Casarico A, Mazzi G, Pappagallo GL; AURO.it BPH Guidelines Committee..

Curr Med Res Opin. 2007 Jul;23(7):1715-32.

PMID:
17588302
3.

Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual function.

Miner M, Rosenberg MT, Perelman MA.

Clin Ther. 2006 Jan;28(1):13-25. Review.

PMID:
16490576
5.

[Medical combination therapy in LUTS suggestive of BPH].

Höfner K, Oelke M.

Urologe A. 2009 Mar;48(3):250-6. doi: 10.1007/s00120-008-1919-7. Review. German.

PMID:
19212753
6.

Comorbid LUTS and erectile dysfunction: optimizing their management.

Kaminetsky J.

Curr Med Res Opin. 2006 Dec;22(12):2497-506. Review.

PMID:
17265598
7.

A practical approach to the management of lower urinary tract symptoms among men.

Woo HH, Gillman MP, Gardiner R, Marshall V, Lynch WJ.

Med J Aust. 2011 Jul 4;195(1):34-9.

PMID:
21728939
8.

Management of lower urinary tract symptoms related to benign prostatic hyperplasia in real-life practice in france: a comprehensive population study.

Lukacs B, Cornu JN, Aout M, Tessier N, Hodée C, Haab F, Cussenot O, Merlière Y, Moysan V, Vicaut E.

Eur Urol. 2013 Sep;64(3):493-501. doi: 10.1016/j.eururo.2013.02.026. Epub 2013 Feb 26.

PMID:
23465519
9.

Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia.

Gacci M, Eardley I, Giuliano F, Hatzichristou D, Kaplan SA, Maggi M, McVary KT, Mirone V, Porst H, Roehrborn CG.

Eur Urol. 2011 Oct;60(4):809-25. doi: 10.1016/j.eururo.2011.06.037. Epub 2011 Jun 29. Review.

PMID:
21726934
10.

Bloodless management of benign prostatic hyperplasia: medical and minimally invasive treatment options.

Liatsikos E, Kyriazis I, Kallidonis P, Stolzenburg JU.

Aging Male. 2011 Sep;14(3):141-9. doi: 10.3109/13685538.2010.548881. Epub 2011 Jan 19. Review.

PMID:
21247241
12.

[Update on current care guidelines: benign prostatic hyperplasia].

Tammela T, Nurmi M, Pétas A, Sipilä R, Taari K.

Duodecim. 2012;128(10):1046-7. Review. Finnish.

PMID:
22724320
13.

Management of benign prostatic hyperplasia by family physicians.

Toguri A, Barkin J.

Can J Urol. 2010 Feb;17 Suppl 1:26-34. Review.

PMID:
20170598
14.

[The current approach to the management of benign hypertrophy of the prostate].

Abbou CC, Salomon L, Chopin D, Ravery V, Haillot O.

Ann Urol (Paris). 1996;30(6-7):294-301; discussion 302-10. French.

PMID:
9092383
15.

Management of patients with LUTS suggestive of BPH.

Gentile M, Carini M, Morgia G, Selvaggi FP, Randone D, Rosati A.

Eur Urol. 2001;40 Suppl 1:5-8.

PMID:
11598346
16.

Monotherapy versus combination drug therapy for the treatment of benign prostatic hyperplasia.

Logan YT, Belgeri MT.

Am J Geriatr Pharmacother. 2005 Jun;3(2):103-14. Review.

PMID:
16129387
17.
18.
19.

The medical management of lower urinary tract symptoms and benign prostatic hyperplasia.

Holtgrewe HL.

Urol Clin North Am. 1998 Nov;25(4):555-69, vii. Review.

PMID:
10026765
20.

[Latest trends and recommendations on epidemiology, diagnosis, and treatment of benign prostatic hyperplasia (BPH)].

Gabuev A, Oelke M.

Aktuelle Urol. 2011 May;42(3):167-78. doi: 10.1055/s-0031-1271453. Epub 2011 May 20. Review. German.

PMID:
21604233

Supplemental Content

Support Center